We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$709M
AUM Growth
+$195M
Cap. Flow
-$68.5M
Cap. Flow %
-9.65%
Top 10 Hldgs %
69.09%
Holding
206
New
48
Increased
50
Reduced
50
Closed
43

Top Buys

Rank Stock Value
1
ATER icon
Aterian
ATER
+$8.44M
2
COCP icon
Cocrystal Pharma
COCP
+$7.74M
3
RCON icon
Recon Technology
RCON
+$7.52M
4
LNAI
Lunai Bioworks
LNAI
+$5.46M
5
KRBP
Kiromic BioPharma, Inc. Common Stock
KRBP
+$4.18M

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$4.81M
2
PENN icon
PENN Entertainment
PENN
+$4.24M
3
VTSI icon
VirTra
VTSI
+$3.45M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$3.42M
5
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$2.4M

Sector Composition

Rank Sector Weight
1 Healthcare 10.24%
2 Consumer Discretionary 1.47%
3 Technology 1.37%
4 Financials 1.09%
5 Consumer Staples 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKYI
101
PUT
BIO-key International
BKYI
$4.61M
$603K 0.09%
9
– –
NCTY
102
CALL
The9 Ltd
NCTY
$70.6M
$602K 0.08%
42
+25
+147% +$4.54K
KUST
103
Kustom Entertainment Inc
KUST
$639K
$598K 0.08%
1
– –
ADMS
104
PUT
DELISTED
Adamas Pharmaceuticals
ADMS
$568K 0.08%
+5,168
New +$26.7K
AMPGW
105
DELISTED
Amplitech Group Warrants
AMPGW
$554K 0.08%
337,599
-4,826
-1% -$11.4K
GLBS icon
106
PUT
Globus Maritime Ltd
GLBS
$60.9M
$543K 0.08%
+1,399
New +$6.36K
NCTY
107
The9 Ltd
NCTY
$70.6M
$526K 0.07%
3,690
+2,861
+345% +$519K
CLRB icon
108
Cellectar Biosciences
CLRB
$20M
$508K 0.07%
1,422
+125
+10% +$54.2K
POL
109
PUT
DELISTED
Polished.com Inc.
POL
$502K 0.07%
+26
New +$7.11K
ATHX
110
DELISTED
Athersys, Inc. Common Stock
ATHX
$497K 0.07%
+13,816
New +$568K
MGNX icon
111
PUT
MacroGenics
MGNX
$245M
$489K 0.07%
182
– –
BIOC
112
PUT
DELISTED
Biocept, Inc.
BIOC
$486K 0.07%
39
+4
+11% +$541
ADTX
113
DELISTED
ADITXT INC
ADTX
– –
0
– –
STKH
114
Steakholder Foods
STKH
$2.13M
$429K 0.06%
53
+8
+18% +$75.2K
JOB icon
115
GEE Group
JOB
$23.1M
$401K 0.06%
+700,000
New +$467K
POL.WS
116
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$385K 0.05%
+180,000
New +$264K
PHIO icon
117
PUT
Phio Pharmaceuticals
PHIO
$11.7M
$366K 0.05%
15
– –
TTNP
118
PUT
DELISTED
Titan Pharmaceuticals
TTNP
$331K 0.05%
64
+1
+2% +$50
BIOC
119
DELISTED
Biocept, Inc.
BIOC
$322K 0.05%
2,563
+514
+25% +$69.6K
EQOS
120
PUT
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$320K 0.05%
488
-104
-18% -$723
OCUL icon
121
Ocular Therapeutix
OCUL
$1.85B
$273K 0.04%
19,217
+9,967
+108% +$152K
DCOY
122
Decoy Therapeutics
DCOY
$2.15M
$264K 0.04%
7
– –
MGNX icon
123
CALL
MacroGenics
MGNX
$245M
$247K 0.03%
92
-196
-68% -$5.74K
PPBT
124
Purple Biotech
PPBT
$1.28M
$247K 0.03%
253
+159
+169% +$146K
CTRM icon
125
Castor Maritime
CTRM
$18.3M
$244K 0.03%
+9,353
New +$380K
3 4
5
6 7

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sabby Management held 206 positions worth $709M, up 38% from $514M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sabby Management withdrew a net $68.5M in Q2 2021, closing 43 positions and reducing 50 holdings. Its most notable exit was PENN Entertainment, an estimated $4.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Sabby Management opened a new position in Aterian worth $6.33M.

  • Sabby Management's largest Q2 2021 buy was Aterian: 36,083 shares worth $6.33M.
  • Sabby Management added most to Vincerx Pharma, Inc. Common Stock in Q2 2021, an estimated $2.87M increase.
  • Sabby Management's biggest Q2 2021 reduction was Vivani Medical, cutting an estimated $4.81M.
  • Sabby Management fully exited PENN Entertainment in Q2 2021, selling an estimated $4.24M.
  • Sabby Management's ten largest holdings make up 69% of its $709M portfolio in Q2 2021.
  • Sabby Management opened 48 new positions and closed 43 in Q2 2021.
  • Sabby Management's portfolio value rose 38% quarter-over-quarter to $709M.

Based on Sabby Management's 13F filing for Q2 2021, filed 16 Aug 2021.